iECURE
Organization
Investors
Investors in iECURE include:1)
Personnel
iECURE - Team2) |
Name | Position | Notes |
Joseph Truitt | CEO and Board Director | BioSpecifics Technologies, Achillion Pharmaceuticals, Larimar Therapeutics, Code BioTherapeutics, United States Marine Corps |
Paul Firuta | Chief Operating Officer | Achillion Pharmaceuticals, uniQure, NPS Pharmaceuticals, ViroPharma |
Alex Monteith | Chief Business Officer | BioSpecifics Technologies, Achillion Pharmaceuticals, Deerfield Management |
David Garrett | Chief Financial Officer | Dynacure, Nabriva Therapeutics, Covis Pharmaceuticals, Auxilium Pharmaceuticals, ViroPharma, KPMG |
Gabriel Cohn | Chief Medical Officer | Homology Medicines, AVROBIO, OvaScience, Shire, American College of Medical Genetics and Genomics, American College of Obstetrics and Gynecology (ACOG), Baystate Medical Center, Tufts University School of Medicine |
George Diaz | VP, Therapeutic Area Lead, Urea Cycle Disorders | Icahn School of Medicine |
James Wilson | Chief Scientific Advisor | Gene Therapy Program, Orphan Disease Center, University of Pennsylvania, Health Through Fitness in Orphan Diseases |
Michael Mitchell | Scientific Advisor | University of Pennsylvania School of Engineering and Applied Science, Gene Therapy Program, Massachusetts Institute of Technology |
External links